An open-label phase II study to evaluate PT2977 for the treatment of von Hippel-Lindau disease-associated renal cell carcinoma.

出版年份 2019 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 7_suppl, Pages TPS680-TPS680

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2019-03-08

DOI

10.1200/jco.2019.37.7_suppl.tps680

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started